COVID-19 caused by SARS-CoV-2 has become a global pandemic requiring the development
of interventions for the prevention or treatment to curtail mortality and morbidity. No …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects cells through
binding to angiotensin-converting enzyme 2 (ACE2). This interaction is mediated by the …

Human rabies remains a globally significant public health problem. Replacement of
polyclonal anti-rabies immunoglobulin (RIG), a passive component of rabies post-exposure …

Coronavirus disease 2019 (COVID-19) is associated with a wide spectrum of disease
presentation, ranging from asymptomatic infection to acute respiratory distress syndrome (ARDS). …

Despite recent advances in therapeutic options, hepatitis C virus (HCV) remains a severe
global disease burden, and a vaccine can substantially reduce its incidence. Due to its …

The Lyme disease (LD) vaccine formerly approved for use in the United States consisted of
recombinant outer surface protein A (OspA) from Borrelia burgdorferi sensu stricto (ss), the …

COVID-19 caused by SARS-CoV-2 has become a global pandemic requiring the development
of interventions for the prevention or treatment to curtail mortality and morbidity. No …

Disrupting transmission of Borrelia burgdorferi sensu lato complex (B. burgdorferi) from
infected ticks to humans is one strategy to prevent the significant morbidity from Lyme disease. …

Enterotoxigenic Escherichia coli (ETEC) causes diarrheal illness in infants in the developing
world and travelers to countries where the disease is endemic, including military personnel. …

Enterotoxigenic Escherichia coli (ETEC) is estimated to cause approximately 380,000
deaths annually during sporadic or epidemic outbreaks worldwide. Development of vaccines …